Top Searches
Advertisement

Caplin Point Prescribes Profits: ₹3 Dividend and Q4 Earnings Surge!

Updated: May 15, 2025 13:34

Image Source: CNBC TV18
Caplin Point Laboratories Ltd declared a dividend of ₹3 per share after reporting strong March quarter (Q4 FY25) financial results, with further growth in revenue and profitability.
 
Caplin Point Laboratories, a prominent Indian pharma firm with a wide presence in emerging economies, posted its March 2025 quarter financial results. The firm has also announced a dividend of ₹3 per share, indicating its robust earnings and focus on shareholder payouts.
 
Dividend Announcement
  • The Board of Directors has approved a dividend payment of ₹3 per share for the year 2024-25.
  • This dividend payment comes on the back of a steady history of rewarding shareholders, with equally sized payouts in earlier quarters and years.
Financial Performance: March Quarter (Q4 FY25)
  • Consolidated Revenue: Consolidated revenue from operations was reported by the company at ₹5.02 billion (₹502 crore) for the quarter ended March 2025.
  • Net Profit: Consolidated net profit was at ₹1.43 billion (₹143 crore) for the same period.
  • Year-on-Year Growth: The company has posted double-digit growth in revenue and net profit over the last year, maintaining its growth trend.
Business Highlights
  • Caplin Point Laboratories continues to consolidate its leadership in Latin America, Africa, and other emerging markets through cost-effective pharmaceutical formulations and injectables.
  • The strong financial performance of the company and consistent dividend distribution reflect its operating efficiency and shareholder orientation.
Board Meeting and Future Outlook
The May 15, 2025, Board meeting approved the audited financial performance and the declaration of interim dividend for FY 2024-25.
 
Caplin Point Laboratories continues to focus on enlarging its market share and providing steady financial performance.
 
Sources: Moneycontrol, Kotak Securities, AlphaStreet, INDmoney, Business Standard, BlinkX Board Meeting Announcement

Advertisement

STORIES YOU MAY LIKE

Image Source: Vajiram & Ravi
RBI Board Puts Economic Capital Buffer Under the Microscope: Five-Year Review Could Shape Future Surplus Transfers
Image Source: Marketfeed
L&T Caps Secondary Stake Buy in E2E Networks at 2.98%, Refines Strategic Cloud Play
Image Source: X
Kridhan Infra Board to Consider Fundraising Options Amidst Challenging Financials
Advertisement
Image Source: Retail Insight Network
US Retail Sales Growth Stalls in April as Consumers Brace for Tariffs, But Yearly Gains Remain Solid
Image Source: X
Techknowgreen Solutions Secures ₹10.5 Million Order, Strengthening Its Environmental Consulting Pipeline
Image Source: Jugyah
Godrej Industries Q4: Revenue Hits ₹57.8 Billion, Net Profit Climbs to ₹1.83 Billion-Signals Steady Growth Momentum
Image Source: The Africa Logistics
Godfrey Phillips India Rewards Shareholders with ₹60 Dividend Amid Strong Q4 Performance
Advertisement
Live Blogs
IPL on the Brink: BCCI Calls Back Foreign Stars as Cricket’s Biggest Showdown Nears Spectacular Return
Middle Menace: CSK’s Middle Order Steals the Spotlight
All Eyes on the New Reign: BCCI to Crown Test Duo, Kohli Exit Still Cloaked
No Toss Yet on IPL 2025: Rajeev Shukla Keeps Fans Guessing
Top Stories
Image Source: Upstox
Rail Vikas Nigam Becomes Lowest Bidder for ₹1.16 Billion Order, Augments Infra Pipeline with Bengaluru Suburban Rail Project
Image Source: Indian Pharma Post
Cyber Side Effects: Alkem Labs’ US Unit Suffers Email Breach and Fund Theft
Golden April: India’s Imports Surge as Investors Seek Safe Haven
Image Source: The Print
Prime Fresh’s Capital Cocktail: 960,000 Warrants, ₹157 Million, One Big Move
Advertisement
Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine